(A) Average fluorescence intensity using different antibody dilutions. Stage 3 hippocampal neurons were stained with anti-acetylated tubulin antibody (Sigma 6-11B-1, 2.2mg/ml) at 4000x, 10,000x, 25,000x, and 50,000x dilutions or anti-polyglutamylated tubulin antibody (GT335, ascites fluid) at 400x, 1000x, 2500x, and 5000x dilutions, or anti-detyrosinated tubulin antibody (Chemicon AB3201, 1mg/ml) at 400x, 1000x, 2500x, and 5000x dilutions. Exposure times were adjusted so that the range of fluorescence signals was similar for each dilution. Fluorescence intensity was quantified by thresholding the entire cell using Metamorph software (n = 10 for each condition) and then adjusted to correct for differences in exposure time. The antibody dilutions used to prepare the figures in the manuscript were 10,000x, 1000x, and 1000x (the boxed points) for acetylated, polyglutamylated and detyrosinated tubulin antibodies, respectively. (B) The sequence of antibody application did not alter the intensity or immunostaining for acetylated, polyglutamylated, or detyrosinated tubulin. Stage 3 hippocampal neurons were fixed with with 4% paraformaldehyde and permeabilized with 0.25% Triton-X 100. Cells were first stained with antibodies against α-tubulin followed by antibodies specific for each PTM, or were first stained with antibodies specific for each PTM followed by anti-αtubulin. The order of antibody application had no effect on the intensity of staining. n =10-11 cells per condition.
Hippocampal neurons were electroporated with dendra2-α-tubulin at the time of plating and microtubule stability was assessed after 3-4 days in culture (see Fig. 2 for details). Cells were preincubated with 10 μM SB216763 for 2 hr or with 10 nM Taxol for 20 min prior to photoconversion of dendra2-αtubulin. Data from 11-14 cells per condition were analyzed using GraphPad Prism 5 (GraphPad Software) (nonlinear regression, two-phase decay). The fitted curves for axons (A) and dendrites (B) are shown together with the mean and SEM at each time point analyzed. (C) The percentage of fluorescence signal in the fast phase under the three different conditions (error bars show 95% confidence intervals). The fraction of stable microtubules increased slightly upon treatment with SB216763 (from about 55% to about 65%) and the calculated half-life of stable microtubules also increased (from 42 to 87 min in dendrites and from 60 to ~200 min in axons), but neither change was statistically significant. By comparison, Taxol treatment resulted in larger, statistically significant increases in the fraction of stable microtubules (to about 80%) and their estimated half-lives (to about 126 min in dendrites and 225 min axons).
Supplemental Figure 4: Treatment with Taxol or tubacin does not alter the polarized distribution of tau-1 and MAP2.
Polarized (stage 3) hippocampal neurons were treated with DMSO, 10nM Taxol, or 10µM Tubacin for 1 hour, then fixed with 4% paraformaldehyde and permeabilized with 0.25% Triton-X 100. Cells were triple-stained with antibodies against αtubulin (Abcam #ab7750, mouse IgG1), tau (tau-1, Chemicon MAB3420, mouse IgG2a specific for a phospho-specific epitope enriched in the axon) and MAP2 (S. Halpain #266 rabbit polyclonal). Note that in some Taxol-treated cells, MAP2 appeared to be more concentrated toward dendrite tips than in control neurons. 
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